Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
DC-1-192
i
Other names:
DC-1-192
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Cardiff University School of Medicine
Drug class:
NF-κB inhibitor
Related drugs:
‹
SBI-756 (2)
BAY-61-3606 (1)
EC-70124 (1)
sodium metaarsenite (1)
SBI-726 (1)
omtriptolide (1)
CBL0102 (1)
ascorbic acid/menadione (0)
BMX-001 (0)
Bay11-7082 (0)
antroquinonol (0)
KLTi (0)
SR13668 (0)
efprezimod alfa (0)
bezisterim (0)
iMX-110 (0)
ETS2101 (0)
ACT001 (0)
GP-2250 (0)
PBI-05204 (0)
SBI-756 (2)
BAY-61-3606 (1)
EC-70124 (1)
sodium metaarsenite (1)
SBI-726 (1)
omtriptolide (1)
CBL0102 (1)
ascorbic acid/menadione (0)
BMX-001 (0)
Bay11-7082 (0)
antroquinonol (0)
KLTi (0)
SR13668 (0)
efprezimod alfa (0)
bezisterim (0)
iMX-110 (0)
ETS2101 (0)
ACT001 (0)
GP-2250 (0)
PBI-05204 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
BIRC3 mutation
Chronic Lymphocytic Leukemia
BIRC3 mutation
Chronic Lymphocytic Leukemia
DC-1-192
Sensitive: D – Preclinical
DC-1-192
Sensitive
:
D
DC-1-192
Sensitive: D – Preclinical
DC-1-192
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.